LYOPHILIZED PEGASPARGASE- pegaspargase injection, powder, lyophilized, for solution 
Baxalta US Inc.

----------

LYOPHILIZED PEGASPARGASE

PRINCIPAL DISPLAY PANEL - Shipping Label

Master Label

Description:

SHIPPER LABEL Lyophilized Pegaspargase for ____________

Item Code:

SL30521XXX 1

User Group:

Materials Management

New [ X ] Revised [ ]

Reason for Master Label:

Weber Archive Name:

Shipper Label.___

Created by/Date:

Approved by/Date:

1 Shipper Labels are site-created components revised by alpha sequence on the label and Master Label document. In
SAP the templates are listed by base item code only.

LYOPHILIZED PEGASPARGASE

Code: 305-21-

Exp. Date: F251-0019-01

Lot #: XXXXX

U/M: Vial

Qty: 60

SL30521

Exelead, Inc.
Indianapolis, IN 46268, USA

999

Shipping Label
LYOPHILIZED PEGASPARGASE 
pegaspargase injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0944-3922
Route of Administration INTRAMUSCULAR
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PEGASPARGASE (UNII: 7D96IR0PPM) (PEGASPARGASE - UNII:7D96IR0PPM) PEGASPARGASE 750 U  in 1 mL
Inactive Ingredients
Ingredient Name Strength
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE (UNII: 5QWK665956)  
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM (UNII: GR686LBA74)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SUCROSE (UNII: C151H8M554)  
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:0944-3922-02 60 in 1 CARTON 02/07/2018
1 NDC:0944-3922-01 5 mL in 1 VIAL, SINGLE-USE; Type 0: Not a Combination Product
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
EXPORT ONLY 02/07/2018
Labeler - Baxalta US Inc. (079887619)
Establishment
Name Address ID/FEI Business Operations
Exelead, Inc 961822389 MANUFACTURE(0944-3922) , PACK(0944-3922) , LABEL(0944-3922)

Revised: 5/2018
Document Id: a4516658-7c78-4c85-b556-6b6109e0d75e
Set id: 2b1212ae-3f17-4e7f-811b-c03c391f5dc3
Version: 3
Effective Time: 20180503
 
Baxalta US Inc.